FDA Approves Tandem’s Insulin Pump

Tandem Diabetes Care received FDA approval and announced the commercial launch of the t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration.

The device is the first sensor-augmented insulin pump approved to let users make treatment decisions without pricking their finger.

The software featured on this pump will also be available to current t:slim X2 Pump users at no cost using the remote software update. This is Tandem’s fifth new insulin pump launch in five years and the second featuring Dexcom technology.